Response Genetics Financials
| RGDXQ Stock | USD 0.0001 0.00 0.00% |
Response |
Response Genetics Stock Summary
Response Genetics, Inc., a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally. Response Genetics, Inc. was founded in 1999 and is headquartered in Los Angeles, California. RESPONSE GENETICS operates under Diagnostics Research classification in the United States and is traded on PNK Exchange. It employs 96 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US76123U1051 |
| Business Address | 1640 Marengo Street, |
| Sector | Life Sciences Tools & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.responsegenetics.com |
| Phone | 323 224 3900 |
| Currency | USD - US Dollar |
Response Genetics Key Financial Ratios
Response Genetics' financial ratios allow both analysts and investors to convert raw data from Response Genetics' financial statements into concise, actionable information that can be used to evaluate the performance of Response Genetics over time and compare it to other companies across industries.Response Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Response Genetics's current stock value. Our valuation model uses many indicators to compare Response Genetics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Response Genetics competition to find correlations between indicators driving Response Genetics's intrinsic value. More Info.Response Genetics is currently regarded as top stock in return on asset category among its peers. It also is currently regarded as top stock in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Response Genetics' earnings, one of the primary drivers of an investment's value.Response Genetics Systematic Risk
Response Genetics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Response Genetics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was sixty with a total number of output elements of one. The Beta measures systematic risk based on how returns on Response Genetics correlated with the market. If Beta is less than 0 Response Genetics generally moves in the opposite direction as compared to the market. If Response Genetics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Response Genetics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Response Genetics is generally in the same direction as the market. If Beta > 1 Response Genetics moves generally in the same direction as, but more than the movement of the benchmark.
Additional Tools for Response Pink Sheet Analysis
When running Response Genetics' price analysis, check to measure Response Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Response Genetics is operating at the current time. Most of Response Genetics' value examination focuses on studying past and present price action to predict the probability of Response Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Response Genetics' price. Additionally, you may evaluate how the addition of Response Genetics to your portfolios can decrease your overall portfolio volatility.